{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Britton D"],"funding":["Cancer Research UK","Medical Research Council","National Institute for Health Research (NIHR)"],"pagination":["e90948"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC3966770"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["9(3)"],"pubmed_abstract":["Objective
LC-MS/MS phospho-proteomics is an essential technology to help unravel the complex molecular events that lead to and propagate cancer. We have developed a global phospho-proteomic workflow to determine activity of signaling pathways and drug targets in pancreatic cancer tissue for clinical application.Methods
Peptides resulting from tryptic digestion of proteins extracted from frozen tissue of pancreatic ductal adenocarcinoma and background pancreas (n = 12), were labelled with tandem mass tags (TMT 8-plex), separated by strong cation exchange chromatography, then were analysed by LC-MS/MS directly or first enriched for phosphopeptides using IMAC and TiO2, prior to analysis. In-house, commercial and freeware bioinformatic platforms were used to identify relevant b"],"journal":["PloS one"],"pubmed_title":["Quantification of pancreatic cancer proteome and phosphorylome: indicates molecular events likely contributing to cancer and activity of drug targets."],"pmcid":["PMC3966770"],"funding_grant_id":["NIHR-RP-011-053","16057","14549","MR/J006742/1"],"pubmed_authors":["Nicholson R","Sarker D","Pike I","Gee J","Quaglia A","Ward M","Selzer S","Stebbing J","Zucht HD","Hoehle C","Schmid P","Koncarevic S","Bohm G","Prefot P","Mitra V","Castellano L","Heaton N","Loβner C","Britton D","Jung S","Zen Y"],"additional_accession":[]},"is_claimable":false,"name":"Quantification of pancreatic cancer proteome and phosphorylome: indicates molecular events likely contributing to cancer and activity of drug targets.","description":"Objective
LC-MS/MS phospho-proteomics is an essential technology to help unravel the complex molecular events that lead to and propagate cancer. We have developed a global phospho-proteomic workflow to determine activity of signaling pathways and drug targets in pancreatic cancer tissue for clinical application.Methods
Peptides resulting from tryptic digestion of proteins extracted from frozen tissue of pancreatic ductal adenocarcinoma and background pancreas (n = 12), were labelled with tandem mass tags (TMT 8-plex), separated by strong cation exchange chromatography, then were analysed by LC-MS/MS directly or first enriched for phosphopeptides using IMAC and TiO2, prior to analysis. In-house, commercial and freeware bioinformatic platforms were used to identify relevant b","dates":{"release":"2014-01-01T00:00:00Z","publication":"2014","modification":"2026-04-29T21:11:54.144Z","creation":"2019-03-26T23:24:23Z"},"accession":"S-EPMC3966770","cross_references":{"pubmed":["24670416"],"doi":["10.1371/journal.pone.0090948"]}}